DRONCIT FELINE CESTOCIDE- praziquantel tablet 
Elanco US Inc.

----------

Elanco™
Droncit®
(praziquantel tablets)
23 Feline Cestocide

CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Each Tablet Contains 23 mg Praziquantel

DESCRIPTION:

Droncit® (praziquantel tablets) 23 Feline Cestocide are sized for easy oral administration to either adult cats or kittens. The tablets may be crumbled and mixed with the feed.

INDICATIONS:

Droncit® (praziquantel tablets) 23 Feline Cestocide are indicated for the removal of the following feline cestodes: Dipylidium caninum and Taenia taeniaeformis.

CONTRAINDICATIONS:

There are no known contraindications to the use of praziquantel in cats.

ACTION:

Droncit® (praziquantel tablets) is absorbed, metabolized in the liver and excreted in the bile. Upon entering the digestive tract from the bile, cestocidal activity is exhibited.1

Following exposure to praziquantel, the tapeworm loses its ability to resist digestion by the mammalian host. Because of this, whole tapeworms, including the scolex, are very rarely passed after administration of praziquantel. In many instances only disintegrated and partially digested pieces of tapeworms will be seen in the stool. The majority of tapeworms killed are digested and are not found in the feces.

USE DIRECTIONS:

Droncit® (praziquantel tablets) 23 Feline Cestocide may be administered directly per os or crumbled and mixed with the feed. The recommended dosage of praziquantel varies according to body weight. Smaller animals require a relatively larger dosage because of their higher metabolic rate. The optimum dose for each individual animal will be achieved by utilizing the following dosage schedule:

Cats and Kittens*
*Not intended for use in kittens less than 6 weeks of age.

4 pounds and under

½ tablet

5-11 pounds

1 tablet

Over 11 pounds

1 ½ tablets

FASTING:

The recommended dosage of praziquantel is not affected by the presence or absence of food in the gastrointestinal tract, therefore, FASTING IS NEITHER NECESSARY NOR RECOMMENDED.

RETREATMENT:

For those animals maintained on premises where reinfections are likely to occur, clients should be instructed in the steps necessary to prevent reinfection; otherwise, retreatment may be necessary. This is especially true in cases of Dipylidium caninum infections where reinfection is almost certain to occur if fleas are not removed from the animal and its environment.

ANIMAL SAFETY:

The safety index has been derived from controlled safety evaluations, clinical trials and prior approved use in foreign countries.

Dosages of 5 times the labeled rate at 14 day intervals to cats as young as 51/2 weeks did not produce clinical signs of toxicity. No significant clinical chemistry, hematological, or histopathological changes occurred. Symptoms of gross overdosage include vomition, salivation, diarrhea and depression.

PREGNANCY:

Droncit® (praziquantel tablets) has been tested in breeding and pregnant cats. No adverse effects were noted.

ADVERSE REACTIONS:

One instance of diarrhea and one of salivation (1.5%) were reported during the field trials in which 135 cats were administered Droncit® (praziquantel tablets) 23 Feline Cestocide.

For medical emergencies or to report adverse reactions, call 1-800-422-9874.

WARNING:

Keep out of the reach of children. Not for human use.

For customer service or to obtain product information, including Safety Data Sheet, call 1-800-633-3796.

STORAGE:

Store at less than or equal to 25ºC (77ºF)

HOW SUPPLIED:

Bottle of 50 and 150 scored tablets.

Each scored tablet contains 23 mg praziquantel.

— 50 Tablets

—150 Tablets

REFERENCES:

1.
Andrews, P. Pharmacokinetic Studies with Droncit in Animals Using a Biological Assay. Veterinary Medical Review 2/76: 154-165.

Elanco US Inc.
Shawnee, Kansas 66216 U.S.A
Made in China
Droncit, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2020 Elanco or its affiliates
Approved by FDA under NADA # 111-798

87037096  LV2009
September, 2020

Elanco™

Principal Display Panel - 50 Tablet Bottle Label

Droncit®

(praziquantel tablets)

23

Feline Cestocide

EACH TABLET CONTAINS: 23 mg praziquantel.

CAUTION: Federal (U.S.A.) law restricts this drug to use by or
on the order of a licensed veterinarian.

WARNING: KEEP OUT OF REACH OF CHILDREN.

50 Tablets

Elanco US Inc. Shawnee, Kansas 66216 USA

Approved by FDA under NADA # 111-798

Made in China

Principal Display Panel - 50 Tablet Bottle Label
DRONCIT FELINE CESTOCIDE 
praziquantel tablet
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:58198-0032
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PRAZIQUANTEL (UNII: 6490C9U457) (PRAZIQUANTEL - UNII:6490C9U457) PRAZIQUANTEL23 mg
Product Characteristics
Colorwhite (white to off white) Score2 pieces
ShapeROUND (ROUND) Size10mm
FlavorImprint Code Droncit;23
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58198-0032-150 in 1 BOTTLE
2NDC:58198-0032-2150 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NADANADA11179812/11/1981
Labeler - Elanco US Inc. (966985624)
Establishment
NameAddressID/FEIBusiness Operations
TriRx Shawnee LLC118187894MANUFACTURE, ANALYSIS, PACK, LABEL
Establishment
NameAddressID/FEIBusiness Operations
Merck KG auf Aktien342249299API MANUFACTURE
Establishment
NameAddressID/FEIBusiness Operations
Hisun Pharmaceutical (Nantong) Co., Ltd.421314476API MANUFACTURE

Revised: 11/2021
Document Id: c190183d-bd61-4238-8f37-3739baf4765b
Set id: de900888-a404-405c-8c55-8ffb5f832234
Version: 4
Effective Time: 20211126
 
Elanco US Inc.